Dr. Rizwan Romee, MD

NPI: 1942493101
Total Payments
$30,853
2024 Payments
$15,409
Companies
7
Transactions
11
Medicare Patients
199
Medicare Billing
$51,287

Payment Breakdown by Category

Travel$11,210 (36.3%)
Consulting$10,434 (33.8%)
Other$8,680 (28.1%)
Food & Beverage$529.28 (1.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $11,210 3 36.3%
Consulting Fee $10,434 2 33.8%
Compensation for serving as faculty or as a speaker for a medical education program $4,760 2 15.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,920 1 12.7%
Food and Beverage $529.28 3 1.7%

Top Paying Companies

Company Total Records Latest Year
F. Hoffmann-La Roche AG $11,489 4 $0 (2024)
EMD Serono, Inc. $6,120 1 $0 (2022)
SERVIER PHARMACEUTICALS LLC $4,760 2 $0 (2022)
GENZYME CORPORATION $4,314 1 $0 (2021)
SANOFI-AVENTIS U.S. LLC $3,920 1 $0 (2024)
Genentech, Inc. $149.78 1 $0 (2022)
Novartis Pharmaceuticals Corporation $100.04 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $15,409 5 F. Hoffmann-La Roche AG ($11,489)
2023 $100.04 1 Novartis Pharmaceuticals Corporation ($100.04)
2022 $11,030 4 EMD Serono, Inc. ($6,120)
2021 $4,314 1 GENZYME CORPORATION ($4,314)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/23/2024 F. Hoffmann-La Roche AG Travel and Lodging Cash or cash equivalent $9,935.45 General
04/23/2024 F. Hoffmann-La Roche AG Travel and Lodging Cash or cash equivalent $1,127.12 General
04/23/2024 F. Hoffmann-La Roche AG Food and Beverage In-kind items and services $279.46 General
04/23/2024 F. Hoffmann-La Roche AG Travel and Lodging Cash or cash equivalent $147.27 General
01/22/2024 SANOFI-AVENTIS U.S. LLC THYMOGLOBULIN (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,920.00 General
Category: Oncology
04/14/2023 Novartis Pharmaceuticals Corporation KYMRIAH (Drug) Food and Beverage In-kind items and services $100.04 General
Category: Oncology
12/09/2022 Genentech, Inc. Food and Beverage In-kind items and services $149.78 General
05/13/2022 SERVIER PHARMACEUTICALS LLC Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $2,380.00 General
05/13/2022 Servier Pharmaceuticals LLC Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $2,380.00 General
03/17/2022 EMD Serono, Inc. Consulting Fee Cash or cash equivalent $6,120.00 General
12/06/2021 GENZYME CORPORATION SARCLISA (Biological) Consulting Fee Cash or cash equivalent $4,314.00 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 46 120 $26,472 $6,686
2022 2 32 108 $43,112 $9,082
2021 2 50 175 $63,025 $14,723
2020 3 71 275 $80,685 $20,795
Total Patients
199
Total Services
678
Medicare Billing
$51,287
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 23 64 $17,792 $4,323 24.3%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 23 56 $8,680 $2,364 27.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 15 71 $28,329 $6,240 22.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 17 37 $14,783 $2,843 19.2%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 30 99 $32,701 $7,969 24.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 20 76 $30,324 $6,755 22.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 37 166 $45,274 $11,219 24.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 22 90 $31,386 $8,257 26.3%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2020 12 19 $4,025 $1,319 32.8%

About Dr. Rizwan Romee, MD

Dr. Rizwan Romee, MD is a Hematology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942493101.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwan Romee, MD has received a total of $30,853 in payments from pharmaceutical and medical device companies, with $15,409 received in 2024. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($11,210).

As a Medicare-enrolled provider, Romee has provided services to 199 Medicare beneficiaries, totaling 678 services with total Medicare billing of $51,287. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Hematology
  • Location Boston, MA
  • Active Since 08/21/2007
  • Last Updated 03/17/2018
  • Taxonomy Code 207RH0000X
  • Entity Type Individual
  • NPI Number 1942493101

Products in Payments

  • SARCLISA (Biological) $4,314
  • THYMOGLOBULIN (Biological) $3,920
  • KYMRIAH (Drug) $100.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology Doctors in Boston